Netilmicin

19405002

New Medicines

External infections of the eye and its adnexa caused by netilmicin sensitive bacteria.

Information

New formulation
NewLine Pharma E.L.
Not Known

Development and Regulatory status

Approved (Licensed)
Launched
None
Dec 19 · Approved in UK for the topical treatment of external infections of the eye and its adnexa caused by netilmicin sensitive bacteria. Available in a single-dose container [1,2].

Category

Netilmicin is an aminoglycoside antibiotic that binds to the bacterial 30S ribosomal subunit and interferes with mRNA binding and the acceptor tRNA site, thus inhibiting protein synthesis in bacteria [3]
Acute infective conjunctivitis accounts for approximately 1% of all GP consultations in the UK. Bacterial conjunctivitis is the second most common cause of infectious conjunctivitis. Between 50–75% of cases of infective conjunctivitis in children are thought to be due to bacterial infection [4].
External infections of the eye and its adnexa caused by netilmicin sensitive bacteria.
Topical